Global Microneedle Drug Delivery Systems Market Size, Status and Forecast 2019-2025
Microneedle drug delivery systems usually include hollow microneedle and solid microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.
Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
In 2018, the global Microneedle Drug Delivery Systems market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Microneedle Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Microneedle Drug Delivery Systems development in United States, Europe and China.
The key players covered in this study
3M
Zosano Pharma
Becton-Dickinson（BD）Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG
Market segment by Type, the product can be split into
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Market segment by Application, split into
Drug Delivery
Vaccine Delivery
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Microneedle Drug Delivery Systems status, future forecast, growth opportunity, key market and key players.
To present the Microneedle Drug Delivery Systems development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Microneedle Drug Delivery Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.
Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
In 2018, the global Microneedle Drug Delivery Systems market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Microneedle Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Microneedle Drug Delivery Systems development in United States, Europe and China.
The key players covered in this study
3M
Zosano Pharma
Becton-Dickinson（BD）Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG
Market segment by Type, the product can be split into
Hollow Microneedle Technology
Solid Microneedle Technology
Dissolving Microneedles Technology
Market segment by Application, split into
Drug Delivery
Vaccine Delivery
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Microneedle Drug Delivery Systems status, future forecast, growth opportunity, key market and key players.
To present the Microneedle Drug Delivery Systems development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Microneedle Drug Delivery Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
